Hesperidin ( DrugBank: Hesperidin )


2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1
93原発性胆汁性胆管炎1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05756179
(ClinicalTrials.gov)
July 202321/2/2023Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid ArthritisClinical Study Evaluating the Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid ArthritisRheumatoid ArthritisDrug: Diosmin and Hesperidin CombinationAlexandria UniversityNULLNot yet recruiting19 Years65 YearsAll80Phase 3NULL

93. 原発性胆汁性胆管炎


臨床試験数 : 298 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs051210210
30/03/202230/03/2022BIG STEPBenefit of glucosyl Hesperidin in patients with primary biliary cholangitis: amulticenter, open-label, randomized control study Primary Biliary Cholangitis
Cholangitis
Participants will be randomly assigned to standard dose and high dose groups.
In standard dose group, hesperidin tablet 500 mg (two tablets at a time once a day after meal) will be orally administered for 24 weeks. In high dose group, hesperidin tablet 1000mg (four tablets at a time once a day after meal) will be orally administered for 24 weeks.
Fujinaga HisayukiNULLRecruiting>= 20age oldNot applicableBoth110Phase 2Japan